These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 10896774

  • 1. Involvement of the [uPAR:uPA:PAI-1:LRP] complex in human myogenic cell motility.
    Chazaud B, Bonavaud S, Plonquet A, Pouchelet M, Gherardi RK, Barlovatz-Meimon G.
    Exp Cell Res; 2000 Aug 01; 258(2):237-44. PubMed ID: 10896774
    [Abstract] [Full Text] [Related]

  • 2. Mitogenic signaling of urokinase receptor-deficient kidney fibroblasts: actions of an alternative urokinase receptor and LDL receptor-related protein.
    Zhang G, Cai X, López-Guisa JM, Collins SJ, Eddy AA.
    J Am Soc Nephrol; 2004 Aug 01; 15(8):2090-102. PubMed ID: 15284295
    [Abstract] [Full Text] [Related]

  • 3. Promigratory effect of plasminogen activator inhibitor-1 on invasive breast cancer cell populations.
    Chazaud B, Ricoux R, Christov C, Plonquet A, Gherardi RK, Barlovatz-Meimon G.
    Am J Pathol; 2002 Jan 01; 160(1):237-46. PubMed ID: 11786417
    [Abstract] [Full Text] [Related]

  • 4. Urokinase type plasminogen activator receptor is involved in insulin-like growth factor-induced migration of rhabdomyosarcoma cells in vitro.
    Gallicchio MA, Kaun C, Wojta J, Binder B, Bach LA.
    J Cell Physiol; 2003 Oct 01; 197(1):131-8. PubMed ID: 12942549
    [Abstract] [Full Text] [Related]

  • 5. Regions involved in binding of urokinase-type-1 inhibitor complex and pro-urokinase to the endocytic alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor.
    Nykjaer A, Kjøller L, Cohen RL, Lawrence DA, Garni-Wagner BA, Todd RF, van Zonneveld AJ, Gliemann J, Andreasen PA.
    J Biol Chem; 1994 Oct 14; 269(41):25668-76. PubMed ID: 7929271
    [Abstract] [Full Text] [Related]

  • 6. Evidence of a non-conventional role for the urokinase tripartite complex (uPAR/uPA/PAI-1) in myogenic cell fusion.
    Bonavaud S, Charrière-Bertrand C, Rey C, Leibovitch MP, Pedersen N, Frisdal E, Planus E, Blasi F, Gherardi R, Barlovatz-Meimon G.
    J Cell Sci; 1997 May 14; 110 ( Pt 9)():1083-9. PubMed ID: 9175704
    [Abstract] [Full Text] [Related]

  • 7. Urokinase/urokinase receptor system: internalization/degradation of urokinase-serpin complexes: mechanism and regulation.
    Conese M, Blasi F.
    Biol Chem Hoppe Seyler; 1995 Mar 14; 376(3):143-55. PubMed ID: 7612191
    [Abstract] [Full Text] [Related]

  • 8. EGF-stimulated migration in ovarian cancer cells is associated with decreased internalization, increased surface expression, and increased shedding of the urokinase plasminogen activator receptor.
    Henic E, Sixt M, Hansson S, Høyer-Hansen G, Casslén B.
    Gynecol Oncol; 2006 Apr 14; 101(1):28-39. PubMed ID: 16263158
    [Abstract] [Full Text] [Related]

  • 9. Binding areas of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex for endocytosis receptors of the low-density lipoprotein receptor family, determined by site-directed mutagenesis.
    Skeldal S, Larsen JV, Pedersen KE, Petersen HH, Egelund R, Christensen A, Jensen JK, Gliemann J, Andreasen PA.
    FEBS J; 2006 Nov 14; 273(22):5143-59. PubMed ID: 17042782
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator.
    Horn IR, van den Berg BM, Moestrup SK, Pannekoek H, van Zonneveld AJ.
    Thromb Haemost; 1998 Nov 14; 80(5):822-8. PubMed ID: 9843178
    [Abstract] [Full Text] [Related]

  • 12. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R, Schaaf A.
    Int J Oncol; 2009 Jan 14; 34(1):15-23. PubMed ID: 19082473
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle.
    Nordengren J, Pilka R, Noskova V, Ehinger A, Domanski H, Andersson C, Høyer-Hansen G, Hansson SR, Casslén B.
    Mol Hum Reprod; 2004 Sep 14; 10(9):655-63. PubMed ID: 15243126
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Wound-induced migration of MDA-MB-435 and SKOV-3 cancer cells is regulated by plasminogen activator inhibitor-1.
    Whitley BR, Church FC.
    Int J Oncol; 2005 Sep 14; 27(3):749-57. PubMed ID: 16077925
    [Abstract] [Full Text] [Related]

  • 18. alpha-2 Macroglobulin receptor/Ldl receptor-related protein(Lrp)-dependent internalization of the urokinase receptor.
    Conese M, Nykjaer A, Petersen CM, Cremona O, Pardi R, Andreasen PA, Gliemann J, Christensen EI, Blasi F.
    J Cell Biol; 1995 Dec 14; 131(6 Pt 1):1609-22. PubMed ID: 8522616
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.